Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01877070 · ClinicalTrials.gov registry record
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
A clinical trial of Low Risk Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 541
- Enrollment target
- 3
- Study locations
NCT01877070 is a study of Low Risk Prostate Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 541 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT01877070, a study of Low Risk Prostate Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 541 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to collect information on how patients and their partners/close allies make treatment decisions when they have been diagnosed with early stage prostate cancer.
Conditions Studied
Interventions
- BEHAVIORAL assessments
Study Locations (3)
New York
- Memorial Sloan Kettering Westchester - Harrison
- Mount Sinai Hospital - New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2013-06 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01877070
The ClinicalTrials.gov registry entry for NCT01877070 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Risk Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which assessments is the first listed.
NCT01877070 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01877070 about?
NCT01877070 is a clinical study titled "Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies". The purpose of this study is to collect information on how patients and their partners/close allies make treatment decisions when they have been diagnosed with early stage prostate cancer.
What is the current status of trial NCT01877070?
This trial is currently active not recruiting. The enrollment target is 541 participants. The study started on 2013-06. Estimated completion is 2026-06.
What conditions does trial NCT01877070 study?
This clinical trial studies the following conditions: Low Risk Prostate Cancer.
What interventions are being tested in trial NCT01877070?
The interventions under investigation include: assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT01877070?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01877070 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.